|
Tuesday, March 27 — 8:00 AM — CC 1 A/B
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt
in the toolbar above as feedback: | |  |
|
Section C - GASTROINTESTINAL PATHOLOGY
Chaired by: Joel Greenson and Wade Samowitz
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Instability of EGFR Gene Status during Progression of Colorectal Cancer
(502)
G De Hertogh, N Personeni, M Debiec-Rychter, J De Schutter, P Van Eyken, K Geboes, E Van Cutsem, S Tejpar - University Hospitals KULeuven, Leuven, Vlaams-Brabant, Belgium
|  Add |
| 8:15 |
High Frequency of Platelet Derived Growth Factor Receptor Alpha Mutations in Gastrointestinal Stromal Tumors: Detection by High Resolution Melting Amplicon Analysis
(524)
JA Holden, C Willmore-Payne, D Coppola, CR Garrett, LJ Layfield University of Utah Health Sciences Center, Salt Lake City, UT; H. Lee Moffitt Cancer and Research Institute, Tampa, FL
| Add |
| 8:30 |
Immunohistochemical Staining for CDX-2, PDX-1, NESP-55, and TTF-1 Can Help Distinguish Gastrointestinal Carcinoid Tumors from Pancreatic Endocrine and Pulmonary Carcinoid Tumors
(587)
A Srivastava, JL Hornick Dartmouth-Hitchcock Medical Center, Lebanon, NH; Brigham and Women's Hospital, Boston, MA
| Add |
| 8:45 |
Fatty Acid Synthase Overexpression in Colorectal Cancer Is Associated with Microsatellite Instability, Independent of CpG Island Methylator Phenotype (CIMP)
(534)
T Kawasaki, CS Fuchs, M Loda, S Ogino Dana-Farber Cancer Inst, Boston, MA; Brigham and Women's Hosp, Boston, MA; Harvard Medical School, Boston, MA
| Add |
| 9:00 |
Differential Gene Expression Profiling of MGMT Deficient Colorectal Cancer Reveals a Carcinogenic Pathway Distinct from Other Mismatch Repair Intact Tumors
(478)
GP Bailey, BS Wittner, S Ramaswamy, MS Redston Brigham and Women's Hospital, Boston, MA; Massachusetts General Hospital, Boston, MA
| Add |
| 9:15 |
MSI-High CIMP-High Colorectal Cancers Show Frequent Down-Regulation of Nuclear p27 (CDKN1B), While Non-MSI Non-CIMP-High Tumors Show Frequent Down-Regulation of p21 (CDKN1A)
(562)
S Ogino, T Kawasaki, GJ Kirkner, A Ogawa, M Loda, CS Fuchs Brigham and Women's Hospital, Boston, MA; Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
Coffee Break sponsored by PathSync
| |
| 11:00 |
Interobserver Variability in the Diagnosis of Hyperplastic and Serrated Colonic Polyps
(561)
RD Odze, K Batts, N Goldstein, S Hamilton, J Jass, M O'Brien, R Riddell, D Snover, H Wang Brigham and Womens Hospital, Boston, MA; Abbott Northwestern Hospital, MN; William Beaumont Hospital, MI; Univ. Texas MD Anderson, TX; McGill Univ, Canada; Boston Medical Center, MA; Mt. Sinai Hospital, Canada; Fairview Southdale Hospital, MN; Beth Israel Deaconess Medical Center, MA
| Add |
| 11:15 |
Serrated Adenomas of the Large Intestine: Loss of Crypt Anchoring Is a Defining Feature of Traditional Versus Sessile Serrated Adenomas
(590)
EE Torlakovic, JD Gomez, T Banerjee, C Wang, Z Gatalica, DC Snover Royal University Hospital, University of Saskatchewan, Saskatoon, SK, Canada; Creighton University Medical Center, Omaha, NE; Fairview Southdale Hospital, Edina, MN
| Add |
| 11:30 |
A Distinct Spectrum of Pathology Is Associated with KRAS Mutations in the Serrated Polyp Neoplasia Pathway
(576)
J Robbins, S Yang, H Xu, C Shepherd, B Burke, C Mark, C Huang, FA Farraye, MJ O'Brien Bost.Univ.Sch.Med, Boston, MA; BMC, Boston, MA
| Add |
| 11:45 |
Prevalence and Clinical Significance of Serrated Lesions in Ulcerative Colitis
(489)
VS Chandan, M Garrity, SC Abraham, TC Smyrk Mayo Clinic, Rochester, MN
| Add |
|
|
